LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 161

Search options

  1. Article ; Online: X-Linked Retinoschisis.

    Ku, Cristy A / Wei, Lisa W / Sieving, Paul A

    Cold Spring Harbor perspectives in medicine

    2023  Volume 13, Issue 9

    Abstract: X-linked retinoschisis (XLRS) is an inherited vitreoretinal dystrophy causing visual impairment in males starting at a young age with an estimated prevalence of 1:5000 to 1:25,000. The condition was first observed in two affected brothers by Josef Haas ... ...

    Abstract X-linked retinoschisis (XLRS) is an inherited vitreoretinal dystrophy causing visual impairment in males starting at a young age with an estimated prevalence of 1:5000 to 1:25,000. The condition was first observed in two affected brothers by Josef Haas in 1898 and is clinically diagnosed by characteristic intraretinal cysts arranged in a petaloid "spoke-wheel" pattern centered in the macula. When clinical electroretinogram (ERG) testing began in the 1960s, XLRS was noted to have a characteristic reduction of the dark-adapted b-wave amplitude despite normal or usually nearly normal a-wave amplitudes, which became known as the "electronegative ERG response" of XLRS disease. The causative gene,
    MeSH term(s) Male ; Humans ; Animals ; Mice ; Retinoschisis/genetics ; Retinoschisis/therapy ; Retinoschisis/diagnosis ; Mutation ; Electroretinography ; Phenotype ; Genetic Therapy ; Eye Proteins/genetics ; Eye Proteins/metabolism ; Retina/metabolism
    Chemical Substances Eye Proteins
    Language English
    Publishing date 2023-09-01
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ISSN 2157-1422
    ISSN (online) 2157-1422
    DOI 10.1101/cshperspect.a041288
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: X-linked Retinoschisis and Gene Therapy.

    Mishra, Alaknanda / Sieving, Paul A

    International ophthalmology clinics

    2021  Volume 61, Issue 4, Page(s) 173–184

    MeSH term(s) Eye Proteins/genetics ; Genetic Therapy ; Humans ; Retinoschisis/genetics ; Retinoschisis/therapy ; Tomography, Optical Coherence
    Chemical Substances Eye Proteins
    Language English
    Publishing date 2021-09-28
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 207382-1
    ISSN 1536-9617 ; 0020-8167
    ISSN (online) 1536-9617
    ISSN 0020-8167
    DOI 10.1097/IIO.0000000000000373
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tissue engineering: NIH competition to create 'eye in a dish'.

    Sieving, Paul A

    Nature

    2017  Volume 546, Issue 7658, Page(s) 352

    MeSH term(s) Humans ; Retina/physiology ; Tissue Engineering
    Language English
    Publishing date 2017--14
    Publishing country England
    Document type Journal Article ; Comment
    ZDB-ID 120714-3
    ISSN 1476-4687 ; 0028-0836
    ISSN (online) 1476-4687
    ISSN 0028-0836
    DOI 10.1038/546352b
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Advances in understanding the molecular structure of retinoschisin while questions remain of biological function.

    Heymann, J Bernard / Vijayasarathy, Camasamudram / Fariss, Robert N / Sieving, Paul A

    Progress in retinal and eye research

    2022  Volume 95, Page(s) 101147

    Abstract: Retinoschisin (RS1) is a secreted protein that is essential for maintaining integrity of the retina. Numerous mutations in RS1 cause X-linked retinoschisis (XLRS), a progressive degeneration of the retina that leads to vision loss in young males. A key ... ...

    Abstract Retinoschisin (RS1) is a secreted protein that is essential for maintaining integrity of the retina. Numerous mutations in RS1 cause X-linked retinoschisis (XLRS), a progressive degeneration of the retina that leads to vision loss in young males. A key manifestation of XLRS is the formation of cavities (cysts) in the retina and separation of the layers (schisis), disrupting synaptic transmission. There are currently no approved treatments for patients with XLRS. Strategies using adeno-associated viral (AAV) vectors to deliver functional copies of RS1 as a form of gene augmentation therapy, are under clinical evaluation. To improve therapeutic strategies for treating XLRS, it is critical to better understand the secretion of RS1 and its molecular function. Immunofluorescence and immunoelectron microscopy show that RS1 is located on the surfaces of the photoreceptor inner segments and bipolar cells. Sequence homology indicates a discoidin domain fold, similar to many other proteins with demonstrated adhesion functions. Recent structural studies revealed the tertiary structure of RS1 as two back-to-back octameric rings, each cross-linked by disulfides. The observation of higher order structures in vitro suggests the formation of an adhesive matrix spanning the distance between cells (∼100 nm). Several studies indicated that RS1 readily binds to other proteins such as the sodium-potassium ATPase (NaK-ATPase) and extracellular matrix proteins. Alternatively, RS1 may influence fluid regulation via interaction with membrane proteins such as the NaK-ATPase, largely inferred from the use of carbonic anhydrase inhibitors to shrink the typical intra-retinal cysts in XLRS. We discuss these models in light of RS1 structure and address the difficulty in understanding the function of RS1.
    MeSH term(s) Male ; Humans ; Molecular Structure ; Retina/metabolism ; Retinoschisis/genetics ; Retinoschisis/metabolism ; Mutation ; Adenosine Triphosphatases/genetics ; Adenosine Triphosphatases/metabolism ; Eye Proteins/genetics
    Chemical Substances Adenosine Triphosphatases (EC 3.6.1.-) ; Eye Proteins
    Language English
    Publishing date 2022-11-16
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1182683-6
    ISSN 1873-1635 ; 1350-9462
    ISSN (online) 1873-1635
    ISSN 1350-9462
    DOI 10.1016/j.preteyeres.2022.101147
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Statistical Evaluation of ERG Responses: A New Method to Validate Cycle-by-Cycle Recordings in Advanced Retinal Degenerations.

    Fadda, Antonello / Martelli, Francesco / Zein, Wadih M / Jeffrey, Brett / Placidi, Giorgio / Sieving, Paul A / Falsini, Benedetto

    Investigative ophthalmology & visual science

    2024  Volume 65, Issue 4, Page(s) 3

    Abstract: Purpose: To describe and evaluate a novel method to determine the validity of measurements made using cycle-by-cycle (CxC) recording techniques in patients with advanced retinal degenerations (RD) having low-amplitude flicker electroretinogram (ERG) ... ...

    Abstract Purpose: To describe and evaluate a novel method to determine the validity of measurements made using cycle-by-cycle (CxC) recording techniques in patients with advanced retinal degenerations (RD) having low-amplitude flicker electroretinogram (ERG) responses.
    Methods: The method extends the original CxC recording algorithm introduced by Sieving et al., retaining the original recording setup and the preliminary analysis of raw data. Novel features include extended use of spectrum analysis, reduction of errors due to known sources, and a comprehensive statistical assessment using three different tests. The method was applied to ERG recordings from seven patients with RD and two patients with CNGB3 achromatopsia.
    Results: The method was implemented as a Windows application to processes raw data obtained from a commercial ERG system, and it features a computational toolkit for statistical assessment of ERG recordings with amplitudes as low as 1 µV, commonly found in advanced RD patients. When recorded using conditions specific for eliciting cone responses, none of the CNGB3 patients had a CxC validated response, indicating that no signal artifacts were present with our recording conditions. A comparison of the presented method with conventional 30 Hz ERG was performed. Bland-Altman plots indicated good agreement (mean difference, -0.045 µV; limits of agreement, 0.193 to -0.282 µV) between the resulting amplitudes. Within-session test-retest variability was 15%, comparing favorably to the variability of standard ERG amplitudes.
    Conclusions: This novel method extracts highly reliable clinical recordings of low-amplitude flicker ERGs and effectively detects artifactual responses. It has potential value both as a cone outcome variable and planning tool in clinical trials on natural history and treatment of advanced RDs.
    MeSH term(s) Humans ; Electroretinography/methods ; Retinal Degeneration/diagnosis ; Retinal Cone Photoreceptor Cells/physiology ; Color Vision Defects ; Photic Stimulation ; Retina/physiology
    Language English
    Publishing date 2024-03-14
    Publishing country United States
    Document type Journal Article
    ZDB-ID 391794-0
    ISSN 1552-5783 ; 0146-0404
    ISSN (online) 1552-5783
    ISSN 0146-0404
    DOI 10.1167/iovs.65.4.3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.

    Vijayasarathy, Camasamudram / Sardar Pasha, Sheik Pran Babu / Sieving, Paul A

    Progress in retinal and eye research

    2021  Volume 87, Page(s) 100999

    Abstract: X-linked Retinoschisis (XLRS) is an early-onset transretinal dystrophy, often with a prominent macular component, that affects males and generally spares heterozygous females because of X-linked recessive inheritance. It results from loss-of-function RS1 ...

    Abstract X-linked Retinoschisis (XLRS) is an early-onset transretinal dystrophy, often with a prominent macular component, that affects males and generally spares heterozygous females because of X-linked recessive inheritance. It results from loss-of-function RS1 gene mutations on the X-chromosome. XLRS causes bilateral reduced acuities from young age, and on clinical exam and by ocular coherence tomography (OCT) the neurosensory retina shows foveo-macular cystic schisis cavities in the outer plexiform (OPL) and inner nuclear layers (INL). XLRS manifests between infancy and school-age with variable phenotypic presentation and without reliable genotype-phenotype correlations. INL disorganization disrupts synaptic signal transmission from photoreceptors to ON-bipolar cells, and this reduces the electroretinogram (ERG) bipolar b-wave disproportionately to photoreceptor a-wave changes. RS1 gene expression is localized mainly to photoreceptors and INL bipolar neurons, and RS1 protein is thought to play a critical cell adhesion role during normal retinal development and later for maintenance of retinal structure. Several independent XLRS mouse models with mutant RS1 were created that recapitulate features of human XLRS disease, with OPL-INL schisis cavities, early onset and variable phenotype across mutant models, and reduced ERG b-wave to a-wave amplitude ratio. The faithful phenotype of the XLRS mouse has assisted in delineating the disease pathophysiology. Delivery to XLRS mouse retina of an AAV8-RS1 construct under control of the RS1 promoter restores the retinal structure and synaptic function (with increase of b-wave amplitude). It also ameliorates the schisis-induced inflammatory microglia phenotype toward a state of immune quiescence. The results imply that XLRS gene therapy could yield therapeutic benefit to preserve morphological and functional retina particularly when intervention is conducted at earlier ages before retinal degeneration becomes irreversible. A phase I/IIa single-center, open-label, three-dose-escalation clinical trial reported a suitable safety and tolerability profile of intravitreally administered AAV8-RS1 gene replacement therapy for XLRS participants. Dose-related ocular inflammation occurred after dosing, but this resolved with topical and oral corticosteroids. Systemic antibodies against AAV8 increased in dose-dependent fashion, but no antibodies were observed against the RS1 protein. Retinal cavities closed transiently in one participant. Technological innovations in methods of gene delivery and strategies to further reduce immune responses are expected to enhance the therapeutic efficacy of the vector and ultimate success of a gene therapy approach.
    MeSH term(s) Animals ; Electroretinography ; Eye Proteins/genetics ; Eye Proteins/metabolism ; Female ; Genetic Therapy/methods ; Humans ; Male ; Mice ; Retina/metabolism ; Retinoschisis/genetics ; Retinoschisis/therapy
    Chemical Substances Eye Proteins
    Language English
    Publishing date 2021-08-11
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1182683-6
    ISSN 1873-1635 ; 1350-9462
    ISSN (online) 1873-1635
    ISSN 1350-9462
    DOI 10.1016/j.preteyeres.2021.100999
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: NEI audacious goals initiative to catalyze innovation.

    Sieving, Paul A

    Investigative ophthalmology & visual science

    2012  Volume 53, Issue 11, Page(s) 7149–7150

    MeSH term(s) Biomedical Research/trends ; Delivery of Health Care, Integrated/trends ; Forecasting ; Health Promotion/trends ; Humans ; National Eye Institute (U.S.)/organization & administration ; Organizational Innovation ; Patient Care Planning/trends ; Patient-Centered Care/trends ; Quality of Health Care ; United States
    Language English
    Publishing date 2012-10
    Publishing country United States
    Document type Editorial
    ZDB-ID 391794-0
    ISSN 1552-5783 ; 0146-0404
    ISSN (online) 1552-5783
    ISSN 0146-0404
    DOI 10.1167/iovs.12-11069
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: MASSIVE ADVANCING NONEXUDATIVE TYPE 1 CHOROIDAL NEOVASCULARIZATION IN CTRP5 LATE-ONSET RETINAL DEGENERATION: Longitudinal Findings on Multimodal Imaging and Implications for Age-Related Macular Degeneration.

    Keenan, Tiarnan D L / Vanderford, Elliott K / de Silva, Tharindu / Sieving, Paul A / Cukras, Catherine A

    Retina (Philadelphia, Pa.)

    2021  Volume 41, Issue 11, Page(s) 2236–2245

    Abstract: Purpose: To describe longitudinal multimodal imaging findings of nonexudative choroidal neovascularization in CTRP5 late-onset retinal degeneration.: Methods: Four patients with CTRP5-positive late-onset retinal degeneration underwent repeated ... ...

    Abstract Purpose: To describe longitudinal multimodal imaging findings of nonexudative choroidal neovascularization in CTRP5 late-onset retinal degeneration.
    Methods: Four patients with CTRP5-positive late-onset retinal degeneration underwent repeated ophthalmoscopic examination and multimodal imaging. All four patients (two siblings and their cousins, from a pedigree described previously) had the heterozygous S163R mutation.
    Results: All four patients demonstrated large subretinal lesions in the mid-peripheral retina of both eyes. The lesions were characterized by confluent hypercyanescence with hypocyanescent borders on indocyanine green angiography, faintly visible branching vascular networks with absent/minimal leakage on fluorescein angiography, Type 1 neovascularization on optical coherence tomography angiography, and absent retinal fluid, consistent with nonexudative choroidal neovascularization. The neovascular membranes enlarged substantially over time and the birth of new membranes was observed, but all lesions remained nonexudative/minimally exudative. Without treatment, all involved retinal areas remained free of atrophy and subretinal fibrosis.
    Conclusion: We report the existence of massive advancing nonexudative Type 1 choroidal neovascularization in CTRP5 late-onset retinal degeneration. These findings have implications for age-related macular degeneration. They provide a monogenic model system for studying the mechanisms underlying the distinct events of choroidal neovascularization development, enlargement, progression to exudation, and atrophy in age-related macular degeneration. They suggest that choroidal hypoperfusion precedes neovascularization and that nonexudative neovascularization may protect against atrophy.
    MeSH term(s) Choroid/blood supply ; Choroid/diagnostic imaging ; Choroidal Neovascularization/diagnosis ; Choroidal Neovascularization/etiology ; Collagen/genetics ; Collagen/metabolism ; DNA Mutational Analysis ; Female ; Fluorescein Angiography/methods ; Fundus Oculi ; Humans ; Male ; Middle Aged ; Multimodal Imaging ; Mutation ; Retinal Degeneration/complications ; Retinal Degeneration/diagnosis ; Retinal Degeneration/genetics ; Severity of Illness Index ; Tomography, Optical Coherence/methods ; Visual Acuity
    Chemical Substances C1QTNF5 protein, human ; Collagen (9007-34-5)
    Language English
    Publishing date 2021-05-14
    Publishing country United States
    Document type Journal Article ; Observational Study
    ZDB-ID 603192-4
    ISSN 1539-2864 ; 0275-004X
    ISSN (online) 1539-2864
    ISSN 0275-004X
    DOI 10.1097/IAE.0000000000003205
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Rs1h

    Zeng, Yong / Qian, Haohua / Campos, Maria Mercedes / Li, Yichao / Vijayasarathy, Camasamudram / Sieving, Paul A

    Gene therapy

    2021  Volume 29, Issue 7-8, Page(s) 431–440

    Abstract: Animal models of X-linked juvenile retinoschisis (XLRS) are valuable tools for understanding basic biochemical function of retinoschisin (RS1) protein and to investigate outcomes of preclinical efficacy and toxicity studies. In order to work with an eye ... ...

    Abstract Animal models of X-linked juvenile retinoschisis (XLRS) are valuable tools for understanding basic biochemical function of retinoschisin (RS1) protein and to investigate outcomes of preclinical efficacy and toxicity studies. In order to work with an eye larger than mouse, we generated and characterized an Rs1h
    MeSH term(s) Animals ; Cell Adhesion Molecules/genetics ; Dietary Supplements ; Electroretinography ; Exons/genetics ; Eye Proteins/genetics ; Eye Proteins/metabolism ; Humans ; Phenotype ; Rats ; Retina/metabolism ; Retinoschisis/genetics ; Retinoschisis/pathology ; Retinoschisis/therapy
    Chemical Substances Cell Adhesion Molecules ; Eye Proteins ; RS1 protein, human
    Language English
    Publishing date 2021-09-22
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, N.I.H., Extramural
    ZDB-ID 1191036-7
    ISSN 1476-5462 ; 0969-7128
    ISSN (online) 1476-5462
    ISSN 0969-7128
    DOI 10.1038/s41434-021-00290-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: At the frontier of vision research: the National Eye Institute celebrates 40 years.

    Sieving, Paul A

    American journal of ophthalmology

    2010  Volume 149, Issue 2, Page(s) 179–181

    MeSH term(s) Biomedical Research/history ; Eye Diseases/history ; History, 20th Century ; History, 21st Century ; Humans ; National Eye Institute (U.S.)/history ; Ophthalmology/history ; United States ; Vision, Ocular
    Language English
    Publishing date 2010-01-25
    Publishing country United States
    Document type Editorial ; Historical Article
    ZDB-ID 80030-2
    ISSN 1879-1891 ; 0002-9394
    ISSN (online) 1879-1891
    ISSN 0002-9394
    DOI 10.1016/j.ajo.2009.10.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top